<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="166651">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02114398</url>
  </required_header>
  <id_info>
    <org_study_id>9162</org_study_id>
    <nct_id>NCT02114398</nct_id>
  </id_info>
  <brief_title>Physiotherapy Efficiency on Child Asthma</brief_title>
  <official_title>Physiotherapy Efficiency With Caycedian Sophrology on Child Asthma: Randomized, Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <authority>France: Committee for the Protection of Personnes</authority>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aim is to compare usual asthma crisis treatment of hospitalized children with
      usual treatment associated to sophrology.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Peak Expiratory Flow (PEF)</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">74</enrollment>
  <condition>Child</condition>
  <condition>Asthma Crisis</condition>
  <arm_group>
    <arm_group_label>usual treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>usual treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>usual treatment + sophrology</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>usual treatment + sophrology</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>usual treatment</intervention_name>
    <description>usual treatment</description>
    <arm_group_label>usual treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>usual treatment + sophrology</intervention_name>
    <description>usual treatment + sophrology</description>
    <arm_group_label>usual treatment + sophrology</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  child (6 to 17 years old)

          -  hospitalized in pediatric unit for asthma crisis

        Exclusion Criteria:

          -  patient who can't participate because of his healthcare (resuscitation...)

          -  impossibility to measure Peak Expiratory Flow (PEF)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pascal AMEDRO, Dr</last_name>
    <email>p-amedro@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>pascal AMEDRO, Dr</last_name>
      <email>p-amedro@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Pascal AMEDRO, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 10, 2014</lastchanged_date>
  <firstreceived_date>February 26, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
